EUVIMEDEUVIMED entdecken
Open Access

Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia

Simonetta I Gaumond, Rama Abdin, Joel Costoya, Andrew V Schally, Joaquin J Jimenez

Oncotarget · 2024

DOI: 10.18632/oncotarget.28579 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncotarget, 2024. Verfasst von Simonetta I Gaumond und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Philip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL 33136, USA. Hauptthemen laut MEDLINE: Growth Hormone-Releasing Hormone, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Growth Hormone-Releasing HormoneLeukemia, Myeloid, AcuteMiceAnimalsHumansMice, NudeCell ProliferationCell Line, TumorDoxorubicinSermorelin

Stichwörter der Autor:innen

AMLMIA-602growth hormone-releasing hormoneleukemiaresistance

Substanzen

GHRH(1-29)NH2, (PhAc-Ada)(0)-Tyr(1), Arg(2), Fpa(5,6), Ala(8), Har(9), Tyr(Me)(10), His(11), Orn(12,) Abu(15), His(20),…Growth Hormone-Releasing HormoneDoxorubicinSermorelin

Autor:innen und Institutionen

  • Dr. Philip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
  • Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, USA.
  • Veterans Affairs Medical Center, Miami, FL 33125, USA.

Zitieren

APA

Gaumond, S. I., Abdin, R., Costoya, J., Schally, A. V., & Jimenez, J. J. (2024). Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia. Oncotarget. https://doi.org/10.18632/oncotarget.28579

Vancouver

Gaumond SI, Abdin R, Costoya J, Schally AV, Jimenez JJ. Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia. Oncotarget. 2024. doi:10.18632/oncotarget.28579

BibTeX
@article{Gaumond2024,
  author = {Gaumond, Simonetta I and Abdin, Rama and Costoya, Joel and Schally, Andrew V and Jimenez, Joaquin J},
  title = {Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia},
  journal = {Oncotarget},
  year = {2024},
  doi = {10.18632/oncotarget.28579}
}
Kostenlos starten →